MASScot does not endorse nor is affiliated with any of the content contained within these links.
- Are changes in fashion, tanning perceptions to blame for rising melanoma rates?
Rates of melanoma have been increasing for at least the past 30 years. Now, a new study published in the American Journal of Public Health claims a number of cultural and historical factors over the past 100 years, such as changes in fashion trends and social perceptions, have contributed to this increase.
Source: Medical News Today
- Doctors explore social factors of melanoma
An increase in cases of melanoma over the past century may be attributed to a variety of social factors, according to a new study.
Source: Net Doctor
- New Standard in Melanoma: Combo of BRAF and MEK Inhibitors
For patients with advanced melanoma that is BRAF-mutation positive, the combination of a BRAF and MEK inhibitor works better than a BRAF inhibitor alone. The data come from 2 phase 3 trials presented here at the presidential session of the European Society for Medical Oncology (ESMO) Congress 2014.
Source: Medscape
- Bristol immune drug shows strong effect in melanoma study
Bristol-Myers Squibb's immunotherapy drug Opdivo produced markedly improved response rates with fewer toxic side effects compared to chemotherapy in a major melanoma study, underscoring its potential as a new treatment option.
Source: Reuters
- Immunotherapy Combinations in Advanced Melanoma
Limited options currently exist for patients with metastatic melanoma who do not have an actionable mutation. In these situations, ipilimumab can be administered as a single-agent, Jeffrey A. Sosman, MD, notes. Additionally, chemotherapy can be administered until a response is achieved followed by a switch to ipilimumab or interleuken-2.
Source: Onc Live
- Australia the first country in the world to see decline in skin cancer rates
Australia is the first country in the world to show an improvement in skin cancer rates, with a small reduction in levels of melanoma and non-melanoma in the under-45 age group.
Source: The Guardian
- Drugs combination could help skin cancer patients extend life
Treating patients suffering from the deadliest form of skin cancer with a combination of drugs could help extend their lives, research has suggested.
Source: Herald Scotland
- Skin cancer patients given fresh hope with University of Manchester research breakthrough
Patients with the most dangerous form of skin cancer could benefit from new research.
Researchers have found that ‘calming down’ the signals from immune cells called macrophages can slow the growth of melanoma tumours.
Source: Manchester Evening News
No comments:
Post a Comment